EVM
AMPH icon

Eaton Vance Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Eaton Vance Management’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,034
Closed -$48K – 1840
2021
Q4 		$48K Buy
2,034
+493
+32% +$10.1K ﹤0.01% 2112
2021
Q3 		$0 Sell
1,541
-5,102
-77% -$99.9K ﹤0.01% 2011
2021
Q2 		$134K Buy
6,643
+6,500
+4,545% +$122K ﹤0.01% 1768
2021
Q1 		$3K Buy
+143
New +$2.66K ﹤0.01% 2687

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Eaton Vance Management's AMPH Position: Q1 2022 in Review

Eaton Vance Management sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2022, closing a stake of 2,034 shares — an estimated $48K sold.

Eaton Vance Management first reported a position in AMPH in Q1 2021 and held it in 4 quarters. The position peaked at $134K in Q2 2021. 203 funds tracked by Wall St. Rank hold AMPH as of Q1 2022.

  • Eaton Vance Management reported no remaining Amphastar Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • Eaton Vance Management sold 2,034 Amphastar Pharmaceuticals shares in Q1 2022, an estimated $48K.
  • Eaton Vance Management first reported a position in Amphastar Pharmaceuticals in Q1 2021 and held it in 4 quarters.
  • Eaton Vance Management's Amphastar Pharmaceuticals position peaked at $134K in Q2 2021.
  • 203 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2022.

Based on Eaton Vance Management's 13F filing for Q1 2022, filed 16 May 2022.